Fig. 1From: Renoprotective effect of SGLT-2 inhibitors among type 2 diabetes patients with different baseline kidney function: a multi-center studyFlow chart of cohort selection. CGMH Chang Gung Memorial Hospital, NCKUH National Cheng Kung University Hospital, NTUH National Taiwan University Hospital, oGLDs other glucose-lowering drugs, SGLT-2is sodium glucose cotransporter-2 inhibitors, T1D type 1 diabetes. *Index date refers to the first date of prescribing SGLT-2is or oGLDs during 2016/05/01–2017/12/31Back to article page